Clinical trials
Prediabetic State trials in Spain with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universidad Católica San Antonio de Murcia | 3 |
| Clinica Universidad de Navarra, Universidad de Navarra | 2 |
| National Research Council, Spain | 2 |
| Universidad de Zaragoza | 2 |
| University of the Balearic Islands | 2 |
| Centro de Edafología y Biología Aplicada del Segura | 1 |
| Evidem Consultores SL | 1 |
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 1 |
| Fundació d'investigació Sanitària de les Illes Balears | 1 |
| Fytexia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 24 |
| Diabetes Mellitus, Type 2 | 8 |
| Overweight | 8 |
| Obesity | 6 |
| Diabetes Mellitus | 5 |
| Insulin Resistance | 3 |
| Glucose Intolerance | 2 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.